KRMD
KORU Medical Systems, Inc.
Price Chart
Latest Quote
$4.28
+0.09 (+2.15%)
Current Price
| Previous Close | $4.19 |
| Open | $4.21 |
| Day High | $4.35 |
| Day Low | $4.20 |
| Volume | 86,560 |
Stock Information
| Shares Outstanding | 45.93M |
| Total Debt | $3.37M |
| Cash Equivalents | $8.77M |
| Revenue | $43.26M |
| Net Income | $-2.28M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $196.59M |
| EPS (TTM) | $-0.05 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $191.19M |
| Sales | $43.26M |
| Income | $-2.28M |
| Book/sh | $0.37 |
| Cash/sh | $0.19 |
| Employees | 73 |
Financial Ratios
| Quick Ratio | 1.70 |
| Current Ratio | 2.33 |
| Debt/Eq | 19.89 |
Returns & Margins
| ROA | -5.81% |
| ROE | -13.70% |
| Gross Margin | 61.93% |
| Operating Margin | -7.35% |
| Profit Margin | -5.27% |
Ownership
| Insider Ownership | 7.96% |
| Institutional Ownership | 57.09% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 53.50 |
| P/S | 4.54 |
| P/B | 11.66 |
Analyst Data
| Recommendation | none |
| Target Price | $6.80 |
Technical Indicators
| SMA20 | $4.02 |
| SMA50 | $4.05 |
| SMA200 | $4.57 |
| RSI | 56.60 |
| ATR | 0.1637 |
| Shares Float | 28.32M |
| Short Float | 1.93% |
| Short Ratio | 5.49 |
| Volatility | 0.42 |
| Rel Volume | 0.76 |
Performance History
| Week | +10.31% |
| Month | +1.90% |
| Quarter | -2.95% |
| 6 Months | -29.49% |
| YTD | -23.71% |
| Year | +20.22% |
| 3 Years | +10.03% |
| 5 Years | -0.70% |
| 10 Years | +1140.58% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $4.28 | 90,629 |
| 2026-06-24 | $4.19 | 150,400 |
| 2026-06-23 | $4.13 | 94,700 |
| 2026-06-22 | $3.86 | 145,400 |
| 2026-06-18 | $3.90 | 396,000 |
| 2026-06-17 | $3.88 | 101,000 |
| 2026-06-16 | $3.94 | 111,200 |
| 2026-06-15 | $3.87 | 116,600 |
| 2026-06-12 | $4.00 | 94,000 |
| 2026-06-11 | $4.00 | 135,300 |
| 2026-06-10 | $3.98 | 108,300 |
| 2026-06-09 | $4.00 | 171,100 |
| 2026-06-08 | $3.99 | 73,300 |
| 2026-06-05 | $3.93 | 58,600 |
| 2026-06-04 | $4.14 | 113,400 |
| 2026-06-03 | $3.92 | 105,600 |
| 2026-06-02 | $4.05 | 97,300 |
| 2026-06-01 | $4.07 | 73,700 |
| 2026-05-29 | $4.06 | 65,900 |
| 2026-05-28 | $4.18 | 70,800 |
| 2026-05-27 | $4.15 | 75,300 |
| 2026-05-26 | $4.20 | 82,900 |
About KORU Medical Systems, Inc.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
đ° Latest News
May 2026 Penny Stocks Worth Watching
Simply Wall St. âĸ 2026-05-08T18:05:00Z
KORU Medical Systems, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00Z
KORU Medical Systems Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T02:16:46Z
We Think KORU Medical Systems (NASDAQ:KRMD) Can Easily Afford To Drive Business Growth
Simply Wall St. âĸ 2026-05-01T11:51:26Z
Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?
Zacks âĸ 2026-03-20T09:38:00Z
KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump
Zacks âĸ 2026-03-17T15:36:00Z
KORU Medical Systems, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-13T12:30:00Z
KORU Medical Systems Inc (KRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-03-13T03:06:01ZKORU Medical Systems Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-13T00:46:43Z
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
Zacks âĸ 2026-03-12T21:35:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $15,523,287 | $12,314,605 | $11,809,384 | $12,527,051 |
| Cost Of Revenue | $15,523,287 | $12,314,605 | $11,809,384 | $12,527,051 |
| Total Revenue | $41,127,366 | $33,646,463 | $28,517,666 | $27,896,037 |
| Operating Revenue | $41,127,366 | $33,646,463 | $28,517,666 | $27,896,037 |
| Expenses | ||||
| Total Expenses | $44,099,808 | $40,092,694 | $38,787,645 | $38,676,910 |
| Other Income Expense | $63,003 | $-62,151 | $-64,931 | $-39,874 |
| Other Non Operating Income Expenses | $9,906 | $-16,160 | - | - |
| Net Non Operating Interest Income Expense | $293,403 | $444,642 | $561,328 | $145,587 |
| Operating Expense | $28,576,521 | $27,778,089 | $26,978,261 | $26,149,859 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Net Interest Income | $293,403 | $444,642 | $561,328 | $145,587 |
| Interest Income | $293,403 | $444,642 | $561,328 | $145,587 |
| Normalized Income | $-2,679,873 | $-6,030,300 | $-13,689,767 | $-8,628,791 |
| Net Income From Continuing And Discontinued Operation | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Total Operating Income As Reported | $-2,972,442 | $-6,446,231 | $-10,269,979 | $-10,780,873 |
| Net Income Common Stockholders | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Net Income | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Net Income Including Noncontrolling Interests | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Net Income Continuous Operations | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Pretax Income | $-2,616,036 | $-6,063,740 | $-9,773,582 | $-10,675,160 |
| Interest Income Non Operating | $293,403 | $444,642 | $561,328 | $145,587 |
| Operating Income | $-2,972,442 | $-6,446,231 | $-10,269,979 | $-10,780,873 |
| Depreciation Amortization Depletion Income Statement | $810,500 | $888,473 | $870,390 | $587,137 |
| Depreciation And Amortization In Income Statement | $810,500 | $888,473 | $870,390 | $587,137 |
| Gross Profit | $25,604,079 | $21,331,858 | $16,708,282 | $15,368,986 |
| Special Income Charges | - | $-16,160 | $-59,807 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.06 | $-0.13 | $-0.30 | $-0.19 |
| Basic EPS | $-0.06 | $-0.13 | $-0.30 | $-0.19 |
| Other | ||||
| Tax Effect Of Unusual Items | $11,150 | $-9,658 | $-13,636 | $-7,523 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,215,039 | $-5,511,767 | $-9,334,658 | $-10,153,862 |
| Total Unusual Items | $53,097 | $-45,991 | $-64,931 | $-39,874 |
| Total Unusual Items Excluding Goodwill | $53,097 | $-45,991 | $-64,931 | $-39,874 |
| Reconciled Depreciation | $810,500 | $888,473 | $870,390 | $587,137 |
| EBITDA (Bullshit earnings) | $-2,161,942 | $-5,557,758 | $-9,399,589 | $-10,193,736 |
| EBIT | $-2,972,442 | $-6,446,231 | $-10,269,979 | $-10,780,873 |
| Diluted Average Shares | $46,187,077 | $45,802,701 | $45,601,346 | $45,002,074 |
| Basic Average Shares | $46,187,077 | $45,802,701 | $45,601,346 | $45,002,074 |
| Diluted NI Availto Com Stockholders | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Tax Provision | $21,890 | $2,893 | $3,967,480 | $-2,014,018 |
| Gain On Sale Of Security | $53,097 | $-45,991 | $-5,124 | $-39,874 |
| Research And Development | $4,387,214 | $5,257,942 | $5,742,254 | $4,956,215 |
| Selling General And Administration | $23,378,807 | $21,631,674 | $20,365,617 | $20,606,507 |
| Gain On Sale Of Ppe | - | $-16,160 | $-59,807 | $0 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $16,363,081 | $16,083,400 | $19,599,410 | $30,538,781 |
| Total Assets | $28,200,179 | $27,218,515 | $28,460,972 | $42,332,443 |
| Total Non Current Assets | $8,211,389 | $8,086,105 | $8,205,043 | $12,530,807 |
| Other Non Current Assets | $98,970 | $98,970 | $98,970 | $102,625 |
| Goodwill And Other Intangible Assets | $684,841 | $730,279 | $754,361 | $787,182 |
| Current Assets | $19,988,790 | $19,132,410 | $20,255,929 | $29,801,636 |
| Other Current Assets | $908,542 | $749,851 | $1,218,288 | $1,457,232 |
| Inventory | $3,678,131 | $2,803,669 | $3,481,301 | $6,404,867 |
| Receivables | $6,529,905 | $5,997,943 | $4,074,100 | $4,531,280 |
| Other Receivables | $639,910 | $499,816 | $28,889 | $972,396 |
| Accounts Receivable | $5,889,995 | $5,498,127 | $4,045,211 | $3,558,884 |
| Cash Cash Equivalents And Short Term Investments | $8,872,212 | $9,580,947 | $11,482,240 | $17,408,257 |
| Cash And Cash Equivalents | $8,872,212 | $9,580,947 | $11,482,240 | $17,408,257 |
| Non Current Deferred Assets | - | - | $0 | $3,967,480 |
| Non Current Deferred Taxes Assets | - | - | $0 | $3,967,480 |
| Allowance For Doubtful Accounts Receivable | - | - | $-24,777 | $-21,459 |
| Gross Accounts Receivable | - | - | $4,069,988 | $3,580,343 |
| Prepaid Assets | - | - | - | $1,457,232 |
| Debt | ||||
| Total Debt | $3,496,260 | $3,990,013 | $4,445,120 | $4,925,004 |
| Long Term Debt And Capital Lease Obligation | $2,957,899 | $3,203,016 | $3,652,923 | $4,047,540 |
| Current Debt And Capital Lease Obligation | $538,361 | $786,997 | $792,197 | $877,464 |
| Current Debt | - | $271,152 | $314,344 | $433,295 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $11,152,257 | $10,404,836 | $8,107,201 | $11,006,480 |
| Total Non Current Liabilities Net Minority Interest | $2,957,899 | $3,203,016 | $3,652,923 | $4,047,540 |
| Current Liabilities | $8,194,358 | $7,201,820 | $4,454,278 | $6,958,940 |
| Other Current Liabilities | $27,722 | $29,269 | $512,520 | $257,337 |
| Current Notes Payable | $0 | $271,152 | $314,344 | $433,295 |
| Payables And Accrued Expenses | $7,628,275 | $6,385,554 | $3,149,561 | $5,824,139 |
| Payables | $2,267,473 | $1,649,969 | $975,193 | $2,391,799 |
| Accounts Payable | $2,267,473 | $1,649,969 | $975,193 | $2,391,799 |
| Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $17,047,922 | $16,813,679 | $20,353,771 | $31,325,963 |
| Total Equity Gross Minority Interest | $17,047,922 | $16,813,679 | $20,353,771 | $31,325,963 |
| Stockholders Equity | $17,047,922 | $16,813,679 | $20,353,771 | $31,325,963 |
| Retained Earnings | $-32,016,832 | $-29,378,906 | $-23,312,273 | $-9,571,211 |
| Other | ||||
| Treasury Shares Number | $3,438,526 | $3,438,526 | $3,420,502 | $3,420,502 |
| Ordinary Shares Number | $46,370,432 | $45,957,115 | $45,669,362 | $45,441,389 |
| Share Issued | $49,808,958 | $49,395,641 | $49,089,864 | $48,861,891 |
| Tangible Book Value | $16,363,081 | $16,083,400 | $19,599,410 | $30,538,781 |
| Invested Capital | $17,047,922 | $17,084,831 | $20,668,115 | $31,759,258 |
| Working Capital | $11,794,432 | $11,930,590 | $15,801,651 | $22,842,696 |
| Capital Lease Obligations | $3,496,260 | $3,718,861 | $4,130,776 | $4,491,709 |
| Total Capitalization | $17,047,922 | $16,813,679 | $20,353,771 | $31,325,963 |
| Treasury Stock | $3,882,494 | $3,882,494 | $3,843,562 | $3,843,562 |
| Additional Paid In Capital | $52,449,339 | $49,581,303 | $47,018,707 | $44,252,117 |
| Capital Stock | $497,909 | $493,776 | $490,899 | $488,619 |
| Common Stock | $497,909 | $493,776 | $490,899 | $488,619 |
| Long Term Capital Lease Obligation | $2,957,899 | $3,203,016 | $3,652,923 | $4,047,540 |
| Current Capital Lease Obligation | $538,361 | $515,845 | $477,853 | $444,169 |
| Current Accrued Expenses | $5,360,802 | $4,735,585 | $2,174,368 | $3,432,340 |
| Net PPE | $7,427,578 | $7,256,856 | $7,351,712 | $7,673,520 |
| Accumulated Depreciation | $-4,067,193 | $-3,472,907 | $-2,721,273 | $-2,794,403 |
| Gross PPE | $11,494,771 | $10,729,763 | $10,072,985 | $10,467,923 |
| Leases | $1,959,045 | $1,953,653 | $1,953,653 | $2,413,820 |
| Other Properties | $8,128,090 | $7,342,488 | $6,707,168 | $6,597,358 |
| Machinery Furniture Equipment | $1,407,636 | $1,433,622 | $1,412,164 | $1,456,745 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-4,020 | $-3,986 | $-250,580 | $-60,118 |
| Finished Goods | $2,949,645 | $1,979,887 | $1,862,525 | $2,611,951 |
| Raw Materials | $732,506 | $827,768 | $1,869,356 | $3,853,034 |
| Current Deferred Revenue | - | - | - | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-494,085 | $-1,661,260 | $-5,707,150 | $-8,206,117 |
| Operating Activities | ||||
| Operating Cash Flow | $462,405 | $-319,718 | $-4,892,553 | $-5,404,549 |
| Cash Flow From Continuing Operating Activities | $462,405 | $-319,718 | $-4,892,553 | $-5,404,549 |
| Operating Gains Losses | $-6,700 | $16,160 | $59,807 | - |
| Investing Activities | ||||
| Capital Expenditure | $-956,490 | $-1,341,542 | $-814,597 | $-2,801,568 |
| Investing Cash Flow | $-949,790 | $-1,333,042 | $-814,597 | $-2,801,568 |
| Cash Flow From Continuing Investing Activities | $-949,790 | $-1,333,042 | $-814,597 | $-2,801,568 |
| Financing Activities | ||||
| Financing Cash Flow | $-221,350 | $-248,533 | $-218,867 | $279,485 |
| Cash Flow From Continuing Financing Activities | $-221,350 | $-248,533 | $-218,867 | $279,485 |
| Net Other Financing Charges | $-27,536 | $-97,379 | $-33,461 | - |
| Issuance Of Capital Stock | - | - | $0 | $406,623 |
| Net Common Stock Issuance | - | - | $0 | $406,623 |
| Common Stock Issuance | - | - | $0 | $406,623 |
| Repurchase Of Capital Stock | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-786,730 | $-638,670 | $-784,039 | $-910,937 |
| Issuance Of Debt | $406,751 | $487,516 | $565,172 | $783,799 |
| Interest Paid Supplemental Data | $55,546 | $71,934 | $50,832 | $28,490 |
| Income Tax Paid Supplemental Data | $14,850 | $0 | $3,160 | $0 |
| End Cash Position | $8,872,212 | $9,580,947 | $11,482,240 | $17,408,257 |
| Beginning Cash Position | $9,580,947 | $11,482,240 | $17,408,257 | $25,334,889 |
| Changes In Cash | $-708,735 | $-1,901,293 | $-5,926,017 | $-7,926,632 |
| Proceeds From Stock Option Exercised | $186,165 | $0 | - | - |
| Net Issuance Payments Of Debt | $-379,979 | $-151,154 | $-218,867 | $-127,138 |
| Net Long Term Debt Issuance | $-379,979 | $-151,154 | $-218,867 | $-127,138 |
| Long Term Debt Payments | $-786,730 | $-638,670 | $-784,039 | $-910,937 |
| Long Term Debt Issuance | $406,751 | $487,516 | $565,172 | $783,799 |
| Net Intangibles Purchase And Sale | $-23,973 | $-44,115 | $-31,648 | $-40,512 |
| Purchase Of Intangibles | $-23,973 | $-44,115 | $-31,648 | $-40,512 |
| Net PPE Purchase And Sale | $-925,817 | $-1,288,927 | $-782,949 | $-2,761,056 |
| Sale Of PPE | $6,700 | $8,500 | $0 | $0 |
| Purchase Of PPE | $-932,517 | $-1,297,427 | $-782,949 | $-2,761,056 |
| Change In Working Capital | $-319,168 | $1,974,968 | $1,203,950 | $1,403,709 |
| Change In Other Current Liabilities | $-1,547 | $-483,250 | $255,183 | $167,337 |
| Change In Payables And Accrued Expense | $1,242,722 | $3,235,993 | $-2,674,578 | $1,726,299 |
| Change In Accrued Expense | $625,218 | $2,561,217 | $-1,257,972 | $562,033 |
| Change In Payable | $617,504 | $674,776 | $-1,416,606 | $1,164,266 |
| Change In Account Payable | $617,504 | $674,776 | $-1,416,606 | $1,164,266 |
| Change In Prepaid Assets | $-196,682 | $220,133 | $242,599 | $28,776 |
| Change In Inventory | $-874,462 | $677,632 | $2,923,566 | $-298,529 |
| Change In Receivables | $-489,199 | $-1,675,540 | $457,180 | $-220,174 |
| Changes In Account Receivables | $-489,199 | $-1,675,540 | $-486,327 | $34,002 |
| Other Non Cash Items | $-97,840 | $243,394 | $-21,988 | $212,546 |
| Stock Based Compensation | $2,713,539 | $2,623,920 | $2,768,870 | $3,079,427 |
| Depreciation Amortization Depletion | $810,500 | $888,473 | $870,390 | $587,137 |
| Depreciation And Amortization | $810,500 | $888,473 | $870,390 | $587,137 |
| Gain Loss On Sale Of PPE | $-6,700 | $16,160 | $59,807 | $0 |
| Net Income From Continuing Operations | $-2,637,926 | $-6,066,633 | $-13,741,062 | $-8,661,142 |
| Deferred Tax | - | $0 | $3,967,480 | $-2,026,226 |
| Deferred Income Tax | - | $0 | $3,967,480 | $-2,026,226 |
| Net Short Term Debt Issuance | - | - | - | $-859,087 |
| Short Term Debt Payments | - | - | - | $-859,087 |
| Change In Other Working Capital | - | - | - | $167,337 |
| Common Stock Payments | - | - | - | - |
| Change In Tax Payable | - | - | - | - |
| Change In Income Tax Payable | - | - | - | - |
| Provisionand Write Offof Assets | - | - | - | - |
Fetched: 2026-06-23